These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26959688)

  • 1. Clinical Efficacy and Safety of Oral Qing-Dai in Patients with Ulcerative Colitis: A Single-Center Open-Label Prospective Study.
    Sugimoto S; Naganuma M; Kiyohara H; Arai M; Ono K; Mori K; Saigusa K; Nanki K; Takeshita K; Takeshita T; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hisamatsu T; Inoue N; Ogata H; Iwao Y; Kanai T
    Digestion; 2016; 93(3):193-201. PubMed ID: 26959688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
    Naganuma M; Sugimoto S; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Suda W; Hattori M; Fukuda S; Hirayama A; Abe T; Watanabe M; Hibi T; Suzuki Y; Kanai T;
    Gastroenterology; 2018 Mar; 154(4):935-947. PubMed ID: 29174928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative Colitis.
    Yoshimatsu Y; Naganuma M; Sugimoto S; Tanemoto S; Umeda S; Fukuda T; Nomura E; Yoshida K; Ono K; Mutaguchi M; Nanki K; Mizuno S; Mikami Y; Fukuhara K; Sujino T; Takabayashi K; Ogata H; Iwao Y; Kanai T
    Digestion; 2020; 101(4):492-498. PubMed ID: 31238326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases.
    Kondo S; Araki T; Okita Y; Yamamoto A; Hamada Y; Katsurahara M; Horiki N; Nakamura M; Shimoyama T; Yamamoto T; Takei Y; Kusunoki M
    Clin J Gastroenterol; 2018 Aug; 11(4):268-272. PubMed ID: 29549501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis.
    Suzuki H; Kaneko T; Mizokami Y; Narasaka T; Endo S; Matsui H; Yanaka A; Hirayama A; Hyodo I
    World J Gastroenterol; 2013 May; 19(17):2718-22. PubMed ID: 23674882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Indigo Naturalis Therapy for Ulcerative Colitis: A Case Series.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Matsumoto T
    Intern Med; 2019 Aug; 58(16):2299-2304. PubMed ID: 31118381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study.
    Gong Y; Zha Q; Li L; Liu Y; Yang B; Liu L; Lu A; Lin Y; Jiang M
    J Ethnopharmacol; 2012 Jun; 141(2):592-8. PubMed ID: 21911045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qing-Dai for pediatric ulcerative colitis multicenter survey and systematic review.
    Kudo T; Jimbo K; Shimizu H; Iwama I; Ishige T; Mizuochi T; Arai K; Kumagai H; Uchida K; Abukawa D; Shimizu T
    Pediatr Int; 2022 Jan; 64(1):e15113. PubMed ID: 35831249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term and long-term outcomes of indigo naturalis treatment for inflammatory bowel disease.
    Matsuno Y; Hirano A; Torisu T; Okamoto Y; Fuyuno Y; Fujioka S; Umeno J; Moriyama T; Nagai S; Hori Y; Fujiwara M; Kitazono T; Esaki M
    J Gastroenterol Hepatol; 2020 Mar; 35(3):412-417. PubMed ID: 31389626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole compounds may be promising medicines for ulcerative colitis.
    Sugimoto S; Naganuma M; Kanai T
    J Gastroenterol; 2016 Sep; 51(9):853-61. PubMed ID: 27160749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis.
    Shen H; Zhang S; Zhao W; Ren S; Ke X; Gu Q; Tang Z; Xie J; Chen S; Chen Y; Zou J; Zhang L; Shen Z; Zheng K; Liu Y; Gu P; Cheng J; Hu J; Zhu L
    Biomed Pharmacother; 2021 Jul; 139():111580. PubMed ID: 33857914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the anti-colitis activities of Qing Dai/Indigo Naturalis constituents in mice.
    Ozawa K; Mori D; Hatanaka A; Sawano T; Nakatani J; Ikeya Y; Nishizawa M; Tanaka H
    J Pharmacol Sci; 2020 Apr; 142(4):148-156. PubMed ID: 32033881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.
    Kubota K; Imai Y; Okuyama T; Ishiyama Y; Ueno S; Kario K
    Int Heart J; 2023; 64(2):316-320. PubMed ID: 37005323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Pulmonary Arterial Hypertension in a Patient Treated with Qing-Dai (Chinese Herbal Medicine).
    Misumi K; Ogo T; Ueda J; Tsuji A; Fukui S; Konagai N; Asano R; Yasuda S
    Intern Med; 2019 Feb; 58(3):395-399. PubMed ID: 30210129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indigo naturalis (Qing dai) for inflammatory bowel disease: A systematic review and meta-analysis.
    Kakdiya R; Jha DK; Choudhury A; Jena A; Sharma V
    Clin Res Hepatol Gastroenterol; 2024 Jan; 48(1):102250. PubMed ID: 38006941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of comprehensive treatment of Chinese medicine in treating ulcerative colitis based on two steps according to the stage of disease].
    Zhou T; Zhang SS; Cui C
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):172-5. PubMed ID: 22574586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study.
    Matsuno Y; Torisu T; Umeno J; Shibata H; Hirano A; Fuyuno Y; Okamoto Y; Fujioka S; Kawasaki K; Moriyama T; Nagasue T; Zeze K; Hirakawa Y; Kawatoko S; Koga Y; Oda Y; Esaki M; Kitazono T
    Intest Res; 2022 Apr; 20(2):260-268. PubMed ID: 35508956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Oral Qing-Dai Medication on Pulmonary Arterial Pressure Levels in Patients With Ulcerative Colitis.
    Orihara Y; Asakura M; Hida N; Kawai M; Sato T; Nishimura K; Masai K; Matsumoto Y; Okuhara Y; Goda A; Masuyama T; Nakamura S; Ishihara M
    Circ J; 2020 Jul; 84(8):1339-1345. PubMed ID: 32595175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Maintenance Effect of Qing Dai for Ulcerative Colitis.
    Suzuki H; Mizokami Y; Gosho M; Kaneko T; Matsui H; Yanaka A
    J Altern Complement Med; 2018 Nov; 24(11):1130-1131. PubMed ID: 29664682
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.
    Ashizuka S; Inatsu H; Kita T; Kitamura K
    Dig Dis Sci; 2016 Mar; 61(3):872-80. PubMed ID: 26470867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.